Distinct phenotype and function of NK cells in the pancreas of nonobese diabetic mice

Journal of Immunology

Volumn 184, Issue 5, 2010, Pages 2272-2280

  Brauner, Hanna ^a   Elemans, Marjet ^a   Lemos, Sara ^a   Broberger, Christian ^a   Holmberg, Dan ^b   Flodström Tullberg, Malin ^a   Kärre, Klas ^a   Höglund, Petter ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b UMEÅ UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; NATURAL KILLER CELL LECTIN LIKE RECEPTOR; CD11B ANTIGEN; CD27 ANTIGEN; DNA BINDING PROTEIN; INTERLEUKIN 2 RECEPTOR; RAG2 PROTEIN, MOUSE;

ADAPTIVE IMMUNITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AUTOIMMUNITY; C57BL 6 MOUSE; CELL FUNCTION; CELL INFILTRATION; CELL PROLIFERATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOKINE RELEASE; DEGRANULATION; DISEASE COURSE; FEMALE; FLOW CYTOMETRY; IMMUNE RESPONSE; IMMUNOFLUORESCENCE; IMMUNOREGULATION; INFLAMMATION; MALE; MOUSE; MOUSE STRAIN; NATURAL KILLER CELL; NONHUMAN; NONOBESE DIABETIC MOUSE; PANCREAS CELL; PHENOTYPE; PRIORITY JOURNAL; SPLEEN; T LYMPHOCYTE; ANIMAL; BAGG ALBINO MOUSE; C3H MOUSE; C57BL MOUSE; FLUORESCENT ANTIBODY TECHNIQUE; GENETICS; IMMUNOLOGY; IMMUNOPHENOTYPING; INSULIN DEPENDENT DIABETES MELLITUS; METABOLISM; MOUSE MUTANT; PANCREAS; PANCREAS ISLET; PATHOLOGY; SPECIES DIFFERENCE;

ANIMALS; ANTIGENS, CD27; CELL PROLIFERATION; DIABETES MELLITUS, TYPE 1; DNA-BINDING PROTEINS; FEMALE; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; IMMUNOPHENOTYPING; ISLETS OF LANGERHANS; KILLER CELLS, NATURAL; MACROPHAGE-1 ANTIGEN; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C3H; MICE, INBRED C57BL; MICE, INBRED NOD; MICE, KNOCKOUT; PANCREAS, EXOCRINE; RECEPTORS, INTERLEUKIN-2; SPECIES SPECIFICITY; T-LYMPHOCYTES;

EID: 77951922471     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0804358     Document Type: Article

References (51)

1. Johansson, S., L. Berg, H. Hall, and P. Höglund. 2005. NK cells: elusive players in autoimmunity. Trends Immunol. 26: 613-618.
2. Ogasawara, K., J. A. Hamerman, L. R. Ehrlich, H. Bour-Jordan, P. Santamaria, J. A. Bluestone, and L. L. Lanier. 2004. NKG2D blockade prevents autoimmune diabetes in NOD mice. Immunity 20: 757-767. (Pubitemid 38757445)
3. Rodacki, M., B. Svoren, V. Butty,W. Besse, L. Laffel, C. Benoist, and D. Mathis. 2007. Altered natural killer cells in type 1 diabetic patients. Diabetes 56: 177-185.
4. Dotta, F., S. Censini, A. G. van Halteren, L. Marselli, M. Masini, S. Dionisi, F. Mosca, U. Boggi, A. O. Muda, S. D. Prato, et al. 2007. Coxsackie B4 virus infection of β cells and natural killer cell insulitis in recent-onset type 1 diabetic patients. Proc. Natl. Acad. Sci. U.S.A. 104: 5115-5120.
5. H1 priming. Nat. Immunol. 5: 1260-1265.
6. Flodström, M., F. D. Shi, N. Sarvetnick, and H. G. Ljunggren. 2002. The natural killer cell - friend or foe in autoimmune disease? Scand. J. Immunol. 55: 432-441.
7. André, I., A. Gonzalez, B. Wang, J. Katz, C. Benoist, and D. Mathis. 1996. Checkpoints in the progression of autoimmune disease: lessons from diabetes models. Proc. Natl. Acad. Sci. U.S.A. 93: 2260-2263.
8. Anderson, M. S., and J. A. Bluestone. 2005. The NOD mouse: a model of immune dysregulation. Annu. Rev. Immunol. 23: 447-485.
9. Poulton, L. D., M. J. Smyth, C. G. Hawke, P. Silveira, D. Shepherd, O. V. Naidenko, D. I. Godfrey, and A. G. Baxter. 2001. Cytometric and functional analyses of NK and NKT cell deficiencies in NOD mice. Int. Immunol. 13: 887-896.
10. Johansson, S. E., H. Hall, J. Björklund, and P. Höglund. 2004. Broadly impaired NK cell function in non-obese diabetic mice is partially restored by NK cell activation in vivo and by IL-12/IL-18 in vitro. Int. Immunol. 16: 1-11.
11. Lee, I. F., H. Qin, J. Trudeau, J. Dutz, and R. Tan. 2004. Regulation of autoimmune diabetes by complete Freund's adjuvant is mediated by NK cells. J. Immunol. 172: 937-942.
12. Poirot, L., C. Benoist, and D. Mathis. 2004. Natural killer cells distinguish innocuous and destructive forms of pancreatic islet autoimmunity. Proc. Natl. Acad. Sci. U.S.A. 101: 8102-8107.
13. Alba, A., R. Planas, X. Clemente, J. Carrillo, R. Ampudia, M. C. Puertas, X. Pastor, E. Tolosa, R. Pujol-Borrell, J. Verdaguer, and M. Vives-Pi. 2008. Natural killer cells are required for accelerated type 1 diabetes driven by interferon-β. Clin. Exp. Immunol. 151: 467-475.
14. Zhang, B., T. Yamamura, T. Kondo, M. Fujiwara, and T. Tabira. 1997. Regulation of experimental autoimmune encephalomyelitis by natural killer (NK) cells. J. Exp. Med. 186: 1677-1687.
15. Matsumoto, Y., K. Kohyama, Y. Aikawa, T. Shin, Y. Kawazoe, Y. Suzuki, and N. Tanuma. 1998. Role of natural killer cells and TCRγ δ T cells in acute autoimmune encephalomyelitis. Eur. J. Immunol. 28: 1681-1688.
16. Shi, F. D., K. Takeda, S. Akira, N. Sarvetnick, and H. G. Ljunggren. 2000. IL-18 directs autoreactive T cells and promotes autodestruction in the central nervous system via induction of IFN-γ by NK cells. J. Immunol. 165: 3099-3104.
17. Shi, F. D., H. B. Wang, H. Li, S. Hong, M. Taniguchi, H. Link, L. Van Kaer, and H. G. Ljunggren. 2000. Natural killer cells determine the outcome of B cellmediated autoimmunity. Nat. Immunol. 1: 245-251.
18. Koopman, L. A., H. D. Kopcow, B. Rybalov, J. E. Boyson, J. S. Orange, F. Schatz, R. Masch, C. J. Lockwood, A. D. Schachter, P. J. Park, and J. L. Strominger. 2003. Human decidual natural killer cells are a unique NK cell subset with immunomodulatory potential. J. Exp. Med. 198: 1201-1212.
19. Croy, B. A., M. J. van den Heuvel, A. M. Borzychowski, and C. Tayade. 2006. Uterine natural killer cells: a specialized differentiation regulated by ovarian hormones. Immunol. Rev. 214: 161-185.
20. Hayakawa, Y., and M. J. Smyth. 2006. CD27 dissects mature NK cells into two subsets with distinct responsiveness and migratory capacity. J. Immunol. 176: 1517-1524. (Pubitemid 43134295)
21. Di Santo, J. P. 2008. Natural killer cells: diversity in search of a niche. Nat. Immunol. 9: 473-475.
22. Vosshenrich, C. A., M. E. García-Ojeda, S. I. Samson- Villéger, V. Pasqualetto, L. Enault, O. Richard-Le Goff, E. Corcuff, D. Guy-Grand, B. Rocha, A. Cumano, et al. 2006. A thymic pathway of mouse natural killer cell development characterized by expression of GATA-3 and CD127. Nat. Immunol. 7: 1217-1224.
23. Yadi, H., S. Burke, Z. Madeja, M. Hemberger, A. Moffett, and F. Colucci. 2008. Unique receptor repertoire in mouse uterine NK cells. J. Immunol. 181: 6140-6147.
24. Höglund, P., J. Mintern, C. Waltzinger, W. Heath, C. Benoist, and D. Mathis. 1999. Initiation of autoimmune diabetes by developmentally regulated presentation of islet cell antigens in the pancreatic lymph nodes. J. Exp. Med. 189: 331-339.
25. Zamboni, I., and C. De Martino. 1967. Buffered picric acid formaldehyde. A new rapid fixative for electron microscopy. J. Cell Biol. 35: 148A.
26. Broberger, C. 1999. Hypothalamic cocaine- and amphetamine-regulated transcript (CART) neurons: histochemical relationship to thyrotropin-releasing hormone, melanin-concentrating hormone, orexin/hypocretin and neuropeptide Y. Brain Res. 848: 101-113. (Pubitemid 30001659)
27. Robbins, S. H., K. B. Nguyen, N. Takahashi, T. Mikayama, C. A. Biron, and L. Brossay. 2002. Cutting edge: inhibitory functions of the killer cell lectin-like receptor G1 molecule during the activation of mouse NK cells. J. Immunol. 168: 2585-2589.
28. Robbins, S. H., M. S. Tessmer, T. Mikayama, and L. Brossay. 2004. Expansion and contraction of the NK cell compartment in response to murine cytomegalovirus infection. J. Immunol. 173: 259-266. (Pubitemid 38797350)
29. Huntington, N. D., H. Tabarias, K. Fairfax, J. Brady, Y. Hayakawa, M. A. Degli-Esposti, M. J. Smyth, D. M. Tarlinton, and S. L. Nutt. 2007. NK cell maturation and peripheral homeostasis is associated with KLRG1 up-regulation. J. Immunol. 178: 4764-4770.
30. Lorini, R., A. Moretta, A. Valtorta, G. d'Annunzio, L. Cortona, L. Vitali, M. Bozzola, and F. Severi. 1994. Cytotoxic activity in children with insulin-dependent diabetes mellitus. Diabetes Res. Clin. Pract. 23: 37-42.
31. Alter,G., J. M. Malenfant, and M. Altfeld. 2004. CD107a as a functionalmarker for the identification of natural killer cell activity. J. Immunol. Methods 294: 15-22. (Pubitemid 39626587)
32. Cheatem, D., B. B. Ganesh, E. Gangi, C. Vasu, and B. S. Prabhakar. 2009. Modulation of dendritic cells using granulocyte-macrophage colony-stimulating factor (GM-CSF) delays type 1 diabetes by enhancing CD4+CD25+ regulatory T cell function. Clin. Immunol. 131: 260-270.
33. Lanier, L. L., D. W. Buck, L. Rhodes, A. Ding, E. Evans, C. Barney, and J. H. Phillips. 1988. Interleukin 2 activation of natural killer cells rapidly induces the expression and phosphorylation of the Leu-23 activation antigen. J. Exp. Med. 167: 1572-1585.
34. Shiow, L. R., D. B. Rosen, N. Brdicková, Y. Xu, J. An, L. L. Lanier, J. G. Cyster, and M. Matloubian. 2006. CD69 acts downstream of interferon-α/β to inhibit S1P1 and lymphocyte egress from lymphoid organs. Nature 440: 540-544.
35. Raulet, D. H. 2003. Roles of the NKG2D immunoreceptor and its ligands. Nat. Rev. Immunol. 3: 781-790.
36. Groh,V., S.Bahram, S.Bauer,A.Herman, M. Beauchamp, and T. Spies. 1996. Cell stress-regulated humanmajor histocompatibility complex class I gene expressed in gastrointestinal epithelium. Proc. Natl. Acad. Sci. U.S.A. 93: 12445-12450.
37. Groh, V., J. Wu, C. Yee, and T. Spies. 2002. Tumour-derived soluble MIC ligands impair expression of NKG2D and T-cell activation. Nature 419: 734-738. (Pubitemid 35177960)
38. Ogasawara, K., J. A. Hamerman, H. Hsin, S. Chikuma, H. Bour-Jordan, T. Chen, T. Pertel, C. Carnaud, J. A. Bluestone, and L. L. Lanier. 2003. Impairment of NK cell function by NKG2D modulation in NOD mice. Immunity 18: 41-51. (Pubitemid 36120686)
39. Sharpe, A. H., E. J. Wherry, R. Ahmed, and G. J. Freeman. 2007. The function of programmed cell death 1 and its ligands in regulating autoimmunity and infection. Nat. Immunol. 8: 239-245.
40. Ansari, M. J., A. D. Salama, T. Chitnis, R. N. Smith, H. Yagita, H. Akiba, T. Yamazaki, M. Azuma, H. Iwai, S. J. Khoury, et al. 2003. The programmed death-1 (PD-1) pathway regulates autoimmune diabetes in nonobese diabetic (NOD) mice. J. Exp. Med. 198: 63-69.
41. Nielsen, C., D. Hansen, S. Husby, B. B. Jacobsen, and S. T. Lillevang. 2003. Association of a putative regulatory polymorphism in the PD-1 gene with susceptibility to type 1 diabetes. Tissue Antigens 62: 492-497. (Pubitemid 37479307)
42. Butcher, S., K. L. Arney, and G. P. Cook. 1998. MAFA-L, an ITIM-containing receptor encoded by the human NK cell gene complex and expressed by basophils and NK cells. Eur. J. Immunol. 28: 3755-3762.
43. Corral, L., T. Hanke, R. E. Vance, D. Cado, and D. H. Raulet. 2000. NK cell expression of the killer cell lectin-like receptor G1 (KLRG1), the mouse homolog of MAFA, is modulated by MHC class I molecules. Eur. J. Immunol. 30: 920-930.
44. Thimme, R., V. Appay, M. Koschella, E. Panther, E. Roth, A. D. Hislop, A. B. Rickinson, S. L. Rowland-Jones, H. E. Blum, and H. Pircher. 2005. Increased expression of the NK cell receptor KLRG1 by virus-specific CD8 T cells during persistent antigen stimulation. J. Virol. 79: 12112-12116. (Pubitemid 41279330)
45. Cardozo, A. K., P. Proost, C. Gysemans, M. C. Chen, C. Mathieu, and D. L. Eizirik. 2003. IL-1β and IFN-γ induce the expression of diverse chemokines and IL-15 in human and rat pancreatic islet cells, and in islets from prediabetic NOD mice. Diabetologia 46: 255-266.
46. de Matos, C. T., L. Berg, J. Michaëlsson, L. Felländer-Tsai, K. Kärre, and K. Söderström. 2007. Activating and inhibitory receptors on synovial fluid natural killer cells of arthritis patients: role of CD94/NKG2A in control of cytokine secretion. Immunology 122: 291-301.
47. Kopcow, H. D., D. S. Allan, X. Chen, B. Rybalov, M. M. Andzelm, B. Ge, and J. L. Strominger. 2005. Human decidual NK cells form immature activating synapses and are not cytotoxic. Proc. Natl. Acad. Sci. U.S.A. 102: 15563-15568.
48. Wherry, E. J., S. J. Ha, S. M. Kaech, W. N. Haining, S. Sarkar, V. Kalia, S. Subramaniam, J. N. Blattman, D. L. Barber, and R. Ahmed. 2007. Molecular signature of CD8+ T cell exhaustion during chronic viral infection. Immunity 27: 670-684.
49. Oppenheim, D. E., S. J. Roberts, S. L. Clarke, R. Filler, J. M. Lewis, R. E. Tigelaar, M. Girardi, and A. C. Hayday. 2005. Sustained localized expression of ligand for the activating NKG2D receptor impairs natural cytotoxicity in vivo and reduces tumor immunosurveillance. Nat. Immunol. 6: 928-937.
50. Feuerer, M., Y. Shen, D. R. Littman, C. Benoist, and D. Mathis. 2009. How punctual ablation of regulatory T cells unleashes an autoimmune lesion within the pancreatic islets. Immunity 31: 654-664.
51. Ralainirina, N., A. Poli, T. Michel, L. Poos, E. Andrès, F. Hentges, and J. Zimmer. 2007. Control of NK cell functions by CD4+CD25+ regulatory T cells. J. Leukoc. Biol. 81: 144-153.